• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

China - An analysis of a stock on the rise of interest in traditional Chinese medicine, bird flu, precision medicine - March 12, 2024

sharon sanders

Editor-in-Chief & President
[FONT=zaker_font_title !important]Analysis of Xiangxue Pharmaceutical's daily limit on March 12: Traditional Chinese medicine, avian influenza, and precision medicine concept hot stocks[/FONT]


According to Securities Star news, Xiangxue Pharmaceutical closed at the daily limit, with a closing price of 4.63 yuan. The stock reached its daily limit at 9:40, but did not open the daily limit. As of closing, the closed order capital was 43.3626 million yuan, accounting for 1.42% of its circulating market value.
In terms of capital flow data on March 12, the net inflow of main funds was 67.6334 million yuan, accounting for 30.84% ​​of the total transaction volume, the net outflow of hot money funds was 30.475 million yuan, accounting for 13.9% of the total transaction volume, and the net outflow of retail funds was 37.1584 million yuan, accounting for 37.1584 million yuan of the total transaction volume. The turnover is 16.95%.
An overview of capital flows in the past five days is shown in the table below: (see chart at link)

The stock is a hot stock with concepts of traditional Chinese medicine, bird flu, and precision medicine. The concept of traditional Chinese medicine rose 3.05% that day, the concept of bird flu rose 2.95%, and the concept of precision medicine rose 2.91%.

The above content is compiled by Securities Star based on public information and generated by algorithms, and has nothing to do with the position of this site. Securities Star strives but does not guarantee the accuracy, completeness, validity, timeliness, etc. of all or part of the information (including but not limited to text, video, audio, data and charts). If you have any questions, please contact us. This article is a compilation of data and does not constitute any investment advice for you. Investments are risky, so please make decisions with caution.

​source: zhttps://app.myzaker.com/news/article.php?pk=65f00d6db15ec0061f19d879
 
Back
Top